HIMS
Hims & Hers Health, Inc.
There isn't enough reported data to score HIMS yet.
TKNO
Alpha Teknova, Inc.
TKNO lost money over the past year, so it has no meaningful PE right now. Analysts expect losses to shrink.
HIMS Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Weak | |
| Stable | |
| Strong |
HIMS's revenue and balance sheet are currently strong, and its cash flow is stable, but its profitability is weak.
TKNO Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Under pressure | |
| Under pressure | |
| Strong |
TKNO's revenue and balance sheet are currently healthy, but its profitability and cash flow are under pressure.
HIMS PE Valuation
HIMS has no meaningful PE right now: it lost money over the past year.
TKNO PE Valuation
TKNO has no meaningful PE right now: it lost money over the past year.
HIMS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Turning to a loss | |
| Strong growth | |
| Stable | |
| Limited | |
| Low |
Analysts expect HIMS's revenue to grow, but its earnings to decline. However, they disagree widely on these estimates.
TKNO Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| High |
TKNO has the edge over HIMS on the outlook, with more favorable earnings and profitability expectations.
HIMS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.83 | -257% |
| Q2 2026 | -$0.63 | -180% |
| Q1 2026 | -$0.09 | -113% |
| Q4 2025 | $0.51 | -3.8% |
| Q3 2025 | $0.53 | +20% |
| Q2 2025 | $0.79 | +888% |
| Q1 2025 | $0.68 | +$0.69 |
| Q4 2024 | $0.53 | +$0.64 |
HIMS has swung to a loss: it lost $0.83 per share over the past year, after a profit the year before.
TKNO Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.28 | +$0.05 |
| Q2 2026 | -$0.30 | +$0.10 |
| Q1 2026 | -$0.31 | +$0.15 |
| Q4 2025 | -$0.32 | +$0.25 |
| Q3 2025 | -$0.33 | +$0.41 |
| Q2 2025 | -$0.40 | +$0.53 |
| Q1 2025 | -$0.46 | +$0.59 |
| Q4 2024 | -$0.57 | +$0.59 |
TKNO has the edge over HIMS on earnings, with more consistent year-over-year improvement.
HIMS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $890.4M | +49% |
| Q2 2026 | $753.2M | +38% |
| Q1 2026 | $608.1M | +3.8% |
| Q4 2025 | $617.8M | +28% |
| Q3 2025 | $599M | +49% |
| Q2 2025 | $544.8M | +73% |
| Q1 2025 | $586M | +111% |
| Q4 2024 | $481.1M | +95% |
HIMS has the edge over TKNO on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -7.4% | -9.4 points |
| Q2 2026 | -13% | -18 points |
| Q1 2026 | -13% | -23 points |
| Q4 2025 | 1.5% | -2.4 points |
| Q3 2025 | 2% | -3.6 points |
| Q2 2025 | 4.9% | +1.4 points |
| Q1 2025 | 9.9% | +6.3 points |
| Q4 2024 | 3.9% | +4 points |
HIMS has the edge over TKNO on profitability, with a higher operating margin.
TKNO Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $12.7M | +22% |
| Q2 2026 | $12.2M | +18% |
| Q1 2026 | $11.1M | +13% |
| Q4 2025 | $10M | +7.8% |
| Q3 2025 | $10.5M | +9.2% |
| Q2 2025 | $10.3M | +7% |
| Q1 2025 | $9.8M | +5.4% |
| Q4 2024 | $9.3M | +18% |
TKNO's revenue has grown year over year for nine quarters in a row: $13M last quarter, up 22% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -25% | +13 points |
| Q2 2026 | -24% | +9.2 points |
| Q1 2026 | -39% | +12 points |
| Q4 2025 | -46% | +15 points |
| Q3 2025 | -38% | +39 points |
| Q2 2025 | -33% | +20 points |
| Q1 2025 | -51% | +35 points |
| Q4 2024 | -61% | +77 points |
TKNO's operating margin was −25% last quarter, up 13 points from the same quarter a year ago.
HIMS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $26M | -67% |
| Q2 2026 | -$68.2M | +$1.3M |
| Q1 2026 | $53.1M | +5.9% |
| Q3 2025 | $79.3M | -7% |
| Q2 2025 | -$69.5M | -230% |
| Q1 2025 | $50.1M | +94% |
| Q3 2024 | $85.3M | +238% |
| Q2 2024 | $53.6M | +219% |
HIMS has the edge over TKNO on cash generation, producing positive trailing cash flow while its opponent burns cash.
TKNO Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.4M | +$969K |
| Q2 2026 | -$596K | +$1.7M |
| Q1 2026 | -$3.6M | +$729K |
| Q4 2025 | -$810K | +$693K |
| Q3 2025 | -$2.4M | +$23K |
| Q2 2025 | -$2.3M | +$645K |
| Q1 2025 | -$4.3M | +$2.4M |
| Q4 2024 | -$1.5M | +$1.7M |
TKNO has burned cash in almost every quarter: −$6M over the past year, against −$10M the year before.
HIMS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.9% | +2.1M shares |
| 1 year | -6% | -14.9M shares |
| 3 years | +11% | +23.7M shares |
| 5 years | +17% | +33.8M shares |
HIMS has the edge over TKNO on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2025 | $80.5M |
| Q3 2025 | $9.5M |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | $5M |
| Q3 2024 | $30M |
| Q2 2024 | $19.9M |
| Q1 2024 | $28.1M |
TKNO Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.1% | +59.6K shares |
| 1 year | +0.3% | +177K shares |
| 3 years | +90% | +25.4M shares |
| 5 years | +106% | +27.6M shares |
TKNO has 54M diluted shares, about the same as a year ago.
| Quarter | Spent |
|---|---|
| Q1 2021 | — |
| Q4 2020 | — |
| Q3 2020 | — |
| Q2 2020 | — |
| Q1 2020 | — |
HIMS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | -5.9x | Net Cash |
| Q4 2025 | -1.4x | Net Cash |
| Q3 2025 | -2.2x | Net Cash |
| Q2 2025 | -7.3x | Net Cash |
| Q1 2025 | -2.1x | Net Cash |
| Q4 2024 | -2.8x | Net Cash |
| Q3 2024 | -2.9x | Net Cash |
| Q2 2024 | -5.5x | Net Cash |
HIMS has more cash than debt.
TKNO Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2021 | -47.1x | Net Cash |
| Q1 2021 | -0.5x | Net Cash |
| Q4 2020 | -0.5x | Net Cash |
TKNO has more cash than debt.
HIMS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 36.0 | Neutral |
| Stochastic | 23.0 | Neutral |
HIMS's weekly RSI is 36 (neutral) and its Stochastic is 23 (neutral).
TKNO Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 61.0 | Neutral |
| Stochastic | 64.2 | Neutral |
TKNO's weekly RSI is 61 (neutral) and its Stochastic is 64 (neutral).
HIMS PE vs Healthcare Sector
| Metric | HIMS | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
HIMS has no meaningful PE right now: it lost money over the past year.
TKNO PE vs Healthcare Sector
TKNO has no meaningful PE right now: it lost money over the past year.
HIMS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $27.3 | 28% below |
| 20 week MA | $29.2 | 32% below |
| 50 week MA | $27.7 | 29% below |
| 100 week MA | $35.9 | 45% below |
| 200 week MA | $24.4 | 19% below |
HIMS is in a downtrend: it's below all five of its weekly moving averages, and 19% below its 200-week average.
TKNO Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $8.02 | 3.4% above |
| 20 week MA | $7.02 | 18% above |
| 50 week MA | $4.94 | 68% above |
| 100 week MA | $5.41 | 53% above |
| 200 week MA | $4.43 | 87% above |
TKNO has the edge over HIMS on trend strength, trading above more of its moving averages.
HIMS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.89 | $15.0 | +51% |
| 2021 | $15.0 | $6.65 | -56% |
| 2022 | $6.65 | $6.43 | -3.3% |
| 2023 | $6.43 | $8.90 | +38% |
| 2024 | $8.90 | $26.6 | +198% |
| 2025 | $26.6 | $34.3 | +29% |
| 2026 YTD | $34.3 | $19.7 | -42% |
HIMS's yearly returns have swung widely, from +198% in 2024 to −56% in 2021. It's down 42% so far in 2026.
TKNO Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $25.0 | $20.4 | -19% |
| 2022 | $20.4 | $5.14 | -75% |
| 2023 | $5.14 | $3.73 | -27% |
| 2024 | $3.73 | $8.73 | +134% |
| 2025 | $8.73 | $4.04 | -54% |
| 2026 YTD | $4.04 | $8.29 | +105% |
TKNO has the edge over HIMS on returns for 2026, with the stronger performance.